Levocabastine Hydrochloride
C26H29FN2O2·HCl
456.98
4-Piperidinecarboxylic acid, 1-[4-cyano-4-(4-fluorophen yl)cyclohexyl]-3-methyl-4-phenyl-, monohydrochloride, (–)-[1(cis),3α,4β]-;
(–)-trans-1-[cis-4-Cyano-4-(p-fluorophenyl)cyclohexyl]-3-methyl-4-phenylisonipecotic acid monohydrochloride [79547-78-7]
4-Piperidinecarboxylic acid, 1-[4-cyano-4-(4-fluorophen yl)cyclohexyl]-3-methyl-4-phenyl-, monohydrochloride, (–)-[1(cis),3α,4β]-;
(–)-trans-1-[cis-4-Cyano-4-(p-fluorophenyl)cyclohexyl]-3-methyl-4-phenylisonipecotic acid monohydrochloride [79547-78-7]
BRIEFING
Levocabastine Hydrochloride. This proposal is based on the version of the monograph official as of May 1, 2020. It is proposed to omit this monograph for the following reasons:
-
No drug products formulated with Levocabastine Hydrochloride are currently marketed in the United States.
-
Drug products containing Levocabastine Hydrochloride are currently not used in veterinary medicine in the United States.
(SM5: S. Cusick)
Case ID—SUB-1048
USP REFERENCE STANDARDS FOR PURCHASE
USP Levocabastine Hydrochloride RSUSP Levocabastine Related Compound A RS